Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis.

Li, Guoxing; Peng, Lihua; Wu, Mingjun; Zhao, Yipin; Cheng, Zhe; Li, Gang

Li, Guoxing; Peng, Lihua; Wu, Mingjun; Zhao, Yipin; Cheng, Zhe; Li, Gang.

Afiliação

Li G; Center for Novel Target and Therapeutic Intervention, Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Peng L; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Wu M; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
Zhao Y; Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Cheng Z; Department of Cardiology, Chongqing University Three Gorges Hospital, Chongqing, China.
Li G; Institute of Life Sciences, Chongqing Medical University, Chongqing, China.

Front Immunol ; 13: 1039510, 2022.

Article em En | MEDLINE | ID: mdl-36601107

Assuntos

Fibrose Pulmonar; Humanos; Animais; Camundongos; Fibrose Pulmonar/genética; Cobre; Apoptose; Bleomicina; Diferenciação Celular

Palavras-chave

ScRNA-seq; TCA cycle; copper; cuproptosis; pulmonary fibrosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google